Is This Dividend King a Screaming Buy?

Maybe there won't be any screaming about this stock. But there could be some buying.Johnson & Johnson (JNJ +0.22%) has been in business since 1886. The company has experienced significant success along the way. However, its share price has never been higher than the levels already achieved in the first few weeks of 2026. CEO Joaquin Duato said in J&J's fourth-quarter update earlier this week that 2025 "kicked off a new era of accelerated growth" for the company. Is the healthcare stock a screaming buy now? ...